- Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwideLouise Justesen Hesselbjerg
Danish Center for Healthcare Improvements, Faculty of Social Sciences and Faculty of Health Sciences, Aalborg University, Denmark
J Med Econ 16:845-58. 2013..80; p = 0.003). The purpose is to review current economic evaluations of these alternatives for healthcare professionals to include these findings in their decision-making...